SYS-CON Media |
GSK Expands Its Asthma and COPD Portfolio in the US
Pharmaceutical Processing GlaxoSmithKline has announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US. Over the past 15 months, GSK has launched four inhaled respiratory therapies in … GSK Expands Its Portfolio Of Medicines In US To Treat Asthma And COPD GSK expands its portfolio of medicines in the US for patients with asthma and … |
View full post on asthma – Google News